{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:36:33Z","timestamp":1794504993937,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023670","name":"The Key Find","doi-asserted-by":"publisher","award":["OLL-1000881"],"award-info":[{"award-number":["OLL-1000881"]}],"id":[{"id":"10.13039\/501100023670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2023-02256"],"award-info":[{"award-number":["2023-02256"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","award":["FoUI-1004114"],"award-info":[{"award-number":["FoUI-1004114"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"King Gustaf V&apos;s 80th Anniversary Fund","doi-asserted-by":"publisher","award":["FAI-2023-1055"],"award-info":[{"award-number":["FAI-2023-1055"]}],"id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-995882"],"award-info":[{"award-number":["R-995882"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-974449"],"award-info":[{"award-number":["SLS-974449"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009800","name":"Professor Nanna Svartz Foundation Fund","doi-asserted-by":"publisher","award":["2021-00436"],"award-info":[{"award-number":["2021-00436"]}],"id":[{"id":"10.13039\/501100009800","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.semarthrit.2026.153031","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:04:32Z","timestamp":1781967872000},"page":"153031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Soluble urokinase plasminogen activator receptor (suPAR) is associated with intrarenal chronicity features on diagnostic and repeat kidney biopsies in lupus nephritis"],"prefix":"10.1016","volume":"79","author":[{"given":"Sandra","family":"J\u00e4gerback","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric A","family":"Houssiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysis","family":"Nikolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wirestam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Enocsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selda","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Lindblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Tamirou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sj\u00f6wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-5395","authenticated-orcid":false,"given":"Ioannis","family":"Parodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2026.153031_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-025-00653-y","article-title":"Lupus nephritis","volume":"11","author":"Parodis","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.153031_bib0004","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153031_bib0005","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3389\/fimmu.2019.01667","article-title":"Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.semarthrit.2026.153031_bib0006","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1001\/archinte.160.20.3136","article-title":"Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995","volume":"160","author":"Ward","year":"2000","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000389","article-title":"Prediction of prognosis and renal outcome in lupus nephritis","volume":"7","author":"Parodis","year":"2020","journal-title":"Lupus Sci Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153031_bib0008","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.39026","article-title":"Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort","volume":"67","author":"Dall'Era","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153031_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble urokinase plasminogen activator receptor (supar) as a biomarker of systemic chronic inflammation","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153031_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.trsl.2013.07.003","article-title":"Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus","volume":"162","author":"Enocsson","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.semarthrit.2026.153031_bib0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2018.00024","article-title":"Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications","volume":"8","author":"Mahmood","year":"2018","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0012","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10238-025-01897-4","article-title":"Interferon alpha-induced uPAR expression on monocytes as a potential source of increased soluble uPAR in patients with SLE at high risk of developing organ damage","volume":"25","author":"Wirestam","year":"2025","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.semarthrit.2026.153031_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102340","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus","volume":"106","author":"Enocsson","year":"2020","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0014","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13075-017-1442-6","article-title":"Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review","volume":"19","author":"Gensous","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153031_bib0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3899\/jrheum.140677","article-title":"Four anti-dsdna antibody assays in relation to systemic lupus erythematosus disease specificity and activity","volume":"42","author":"Enocsson","year":"2015","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153031_bib0016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.kint.2021.09.012","article-title":"The lupus nephritis management renaissance","volume":"101","author":"Mejia-Vilet","year":"2022","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153031_bib0017","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/rheumatology\/keae023","article-title":"Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab","volume":"64","author":"J\u00e4gerback","year":"2025","journal-title":"Rheumatol (Oxf)"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000018","article-title":"Role of early repeated renal biopsies in lupus nephritis","volume":"1","author":"Zickert","year":"2014","journal-title":"Lupus Sci Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153031_bib0019","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/ndt\/gfv296","article-title":"Histologic versus clinical remission in proliferative lupus nephritis","volume":"32","author":"Malvar","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153031_bib0020","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1093\/rheumatology\/keaa129","article-title":"Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis","volume":"59","author":"Parodis","year":"2020","journal-title":"Rheumatol (Oxf)"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153031_bib0021","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/art.43427","article-title":"Biomarkers of lupus nephritis histopathology: where do we stand?","volume":"78","author":"Querin","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"19","key":"10.1016\/j.semarthrit.2026.153031_bib0022","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.3390\/jcm11195759","article-title":"Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature","volume":"11","author":"Palazzo","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0023","doi-asserted-by":"crossref","DOI":"10.1172\/JCI197141","article-title":"The role of suPAR and related proteins in kidney, heart diseases, and diabetes","volume":"136","author":"Reiser","year":"2026","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2026.153031_bib0024","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2022.12.005","article-title":"Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function","volume":"373","author":"M\u00f6rtberg","year":"2023","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153031_bib0025","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153031_bib0026","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.trsl.2014.09.007","article-title":"Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease","volume":"165","author":"Sj\u00f6wall","year":"2015","journal-title":"Transl Res"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153031_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247256","article-title":"Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis","volume":"16","author":"Butt","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153031_bib0028","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/acr2.11585","article-title":"Epidemiology and damage accrual of systemic lupus erythematosus in central sweden: a single-center population-based cohort study over 14\u2009years from \u00f6sterg\u00f6tland county","volume":"5","author":"Arkema","year":"2023","journal-title":"ACR Open Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153031_bib0029","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153031_bib0030","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153031_bib0031","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153031_bib0032","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153031_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103810","article-title":"Lupus nephritis trials network (LNTN) repeat kidney biopsy-based definitions of treatment response: A systematic literature review-based proposal","volume":"24","author":"Parodis","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0034","first-page":"36","article-title":"IFN-\u03b3, CXCL16, uPAR: potential biomarkers for systemic lupus erythematosus","volume":"36","author":"Wen","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153031_bib0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/0961203314558857","article-title":"Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: a large cohort study from China","volume":"24","author":"Qin","year":"2015","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000932","article-title":"Remission of lupus nephritis: the trajectory of histological response in successfully treated patients","volume":"10","author":"Malvar","year":"2023","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000270","article-title":"Interferon pathway in SLE: one key to unlocking the mystery of the disease","volume":"6","author":"R\u00f6nnblom","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.semarthrit.2026.153031_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103025","article-title":"Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus","volume":"136","author":"Lindblom","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2026.153031_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2025.100296","article-title":"Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus","volume":"11","author":"Lindblom","year":"2025","journal-title":"J Transl Autoimmun"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153031_bib0040","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ekir.2024.03.014","article-title":"Interferon and b-cell signatures inform precision medicine in lupus nephritis","volume":"9","author":"Parodis","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153031_bib0041","article-title":"WCN25-2746 Urokinase plasminogen activator receptor upregulation in lupus nephritis associates with distinct interferon hub genes in stressed podocytes","volume":"10","author":"Tampe","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.semarthrit.2026.153031_bib0042","article-title":"suPAR and WT1 modify the adhesion of podocytes and are related to proteinuria in class IV lupus nephritis","volume":"7","author":"Bollain","year":"2023","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.semarthrit.2026.153031_bib0043","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.trsl.2021.02.007","article-title":"Serum levels of the soluble urokinase plasminogen activator receptor (suPAR) correlates with disease activity in early rheumatoid arthritis and reflects joint damage over time","volume":"232","author":"Enocsson","year":"2021","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153031_bib0044","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00005-022-00646-9","article-title":"Treat-to-target in lupus nephritis. what is the role of the repeat kidney biopsy?","volume":"70","author":"Parodis","year":"2022","journal-title":"Arch Immunol Ther Exp (Warsz)"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:09:21Z","timestamp":1785888561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"alternative-id":["S0049017226001216"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153031","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble urokinase plasminogen activator receptor (suPAR) is associated with intrarenal chronicity features on diagnostic and repeat kidney biopsies in lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153031"}}